Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Enzyme Replacement Therapy Market Evolve in Terms of Growth and Size by 2029?

The market size for enzyme replacement therapy has witnessed significant expansion in the past few years. The market valuation will elevate from $11.58 billion in 2024 to $12.36 billion in 2025, manifesting a compound annual growth rate (CAGR) of 6.7%. The progression during the historical period is linked to the advancements in early-stage therapeutic discoveries, groundbreaking treatment approvals, enhanced disease comprehension, clinical achievements, as well as supportive regulatory policies and incentives.

Expectations are high for the enzyme replacement therapy market to experience significant expansion in the coming years. The market size is projected to reach “$17.48 billion by 2029”, increasing at a compound annual growth rate (CAGR) of “9.0%”. This anticipated growth during the forecast period can be ascribed to factors such as improved patient accessibility to healthcare, the development of customized therapies and precision medicine, alterations in the regulatory environment, and heightened awareness among patient populations. Key trends projected to be prevalent in the future include the integration of digital health, a concentration on patient-focused solutions, the rise of biomarker research, and the approach towards precision medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10512&type=smp

What factors are expected to fuel Enzyme Replacement Therapy market growth in the coming years?

The escalating incidence of uncommon, long-term and genetically transmitted diseases is projected to stimulate the expansion of the enzyme replacement therapy market in the future. A chronic disease is a type of illness that persists for more than three months and may progressively worsen. Older individuals are more often affected by these conditions which can typically be managed but not eliminated. For example, according to the American Lung Association, a non-profit organization based in the US, it was reported in July 2024 that in 2022, 44.2 million Americans, representing 13.5% of the population, had been diagnosed with asthma by a medical practitioner, a rise from 12.9% in 2021. Thus, the increasing incidence of uncommon, chronic and genetically transmitted diseases are key in promoting the growth of the enzyme replacement therapy market.

The enzyme replacement therapy market covered in this report is segmented –

1) By Enzyme Type: Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types

2) By Route Of Administration: Oral, Parenteral

3) By Application: Gaucher Disease, Pompe Disease, Fabry Disease, Other Applications

4) By End-Users: Hospitals, Infusion Centers, Other End-Users

Subsegments:

1) By Agalsidase Alfa: Fabry Disease Treatment

2) By Agalsidase Beta: Fabry Disease Treatment

3) By Galsulfase: Mucopolysaccharidosis VI (MPS VI) Treatment

4) By Other Enzyme Types: Alglucosidase Alfa, Idursulfase, Velaglucerase Alfa

What Notable Trends Are Shaping The Direction Of The Enzyme Replacement Therapy Market?

The surge in product approvals has become a significant trend in the enzyme replacement therapy market. Many enzyme replacement therapies developed by major industry players are receiving endorsements. For instance, Lamzede (velmanase alfa) was sanctioned by the Food and Drug Administration, an agency under the United States’ Department of Health, in February 2023. This particular therapy is the inaugural one to be approved in the U.S. for treating non-central neurological indications of alpha-mannosidosis, a rare genetic condition defined by the body’s lack of the alpha-mannosidase enzyme. Lamzede operates in a way similar to the alpha-mannosidase enzyme in patients’ bodies, thereby normalizing cellular functions. It is delivered to patients as a 10mg injection once weekly.

What Are The Most Active Companies In The Enzyme Replacement Therapy Market Today?

Major companies operating in the enzyme replacement therapy market include Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Johnson & Johnson Services Inc., Alexion Pharmaceuticals Inc., Recordati Rare Diseases Inc., Sangamo Therapeutics Inc., JCR Pharmaceuticals Co. Ltd., Horizon Pharma Public Limited Company, Protalix Biotherapeutics Ltd., Amicus Therapeutics Inc., AstraZeneca plc, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Retrophin Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Ultragenyx Pharmaceutical Inc.

https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report

Which Regional Markets Are Attracting The Most Investment In Enzyme Replacement Therapy?

North America was the largest region in the enzyme replacement therapy market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global enzyme replacement therapy market report during the forecast period. The regions covered in the enzyme replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10512&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model